
USD
+$0.00
(+0.00%
)At Close (As of Nov 28, 2025)
$95.20M
Market Cap
-
P/E Ratio
-0.83
EPS
$5.92
52 Week High
$0.98
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $54M |
| Total Revenue | $75M |
| Cost Of Revenue | $21M |
| Costof Goods And Services Sold | $21M |
| Operating Income | -$35M |
| Selling General And Administrative | $30M |
| Research And Development | $13M |
| Operating Expenses | $89M |
| Investment Income Net | - |
| Net Interest Income | -$7.3M |
| Interest Income | - |
| Interest Expense | $7.3M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $2.1M |
| Income Before Tax | -$44M |
| Income Tax Expense | -$14K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$44M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$36M |
| Ebitda | -$34M |
| Net Income | -$44M |
| Field | Value (USD) |
|---|---|
| Total Assets | $141M |
| Total Current Assets | $58M |
| Cash And Cash Equivalents At Carrying Value | $19M |
| Cash And Short Term Investments | $19M |
| Inventory | $4.2M |
| Current Net Receivables | $24M |
| Total Non Current Assets | $83M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $20M |
| Intangible Assets Excluding Goodwill | $20M |
| Goodwill | $19M |
| Investments | - |
| Long Term Investments | $86K |
| Short Term Investments | $206K |
| Other Current Assets | $9.9M |
| Other Non Current Assets | - |
| Total Liabilities | $109M |
| Total Current Liabilities | $31M |
| Current Accounts Payable | $11M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $4.8M |
| Total Non Current Liabilities | $78M |
| Capital Lease Obligations | $27M |
| Long Term Debt | $55M |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $83M |
| Other Current Liabilities | $14M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $28M |
| Treasury Stock | - |
| Retained Earnings | -$420M |
| Common Stock | $557K |
| Common Stock Shares Outstanding | $32M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$31M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $2.1M |
| Capital Expenditures | $1.5M |
| Change In Receivables | - |
| Change In Inventory | $3.2M |
| Profit Loss | - |
| Cashflow From Investment | -$2.4M |
| Cashflow From Financing | -$6.8M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$44M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $54M |
| Total Revenue | $75M |
| Cost Of Revenue | $21M |
| Costof Goods And Services Sold | $21M |
| Operating Income | -$35M |
| Selling General And Administrative | $30M |
| Research And Development | $13M |
| Operating Expenses | $89M |
| Investment Income Net | - |
| Net Interest Income | -$7.3M |
| Interest Income | - |
| Interest Expense | $7.3M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $2.1M |
| Income Before Tax | -$44M |
| Income Tax Expense | -$14K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$44M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$36M |
| Ebitda | -$34M |
| Net Income | -$44M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Neuronetics, Inc. (STIM) is a commercial-stage medical technology company based in Malvern, Pennsylvania, focused on developing and marketing innovative non-invasive therapeutic solutions for psychiatric disorders, particularly major depressive disorder and obsessive-compulsive disorder. The company utilizes its proprietary neurostimulation technology to provide effective treatment options, addressing the increasing demand for advanced mental health therapies. With a strong dedication to enhancing patient outcomes, Neuronetics is strategically positioned to capitalize on the growth opportunities within the global mental health care market.